Literature DB >> 15122520

Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.

Lijuan Yuan1, Shin-Ichi Ishida, Shinjiro Honma, John T Patton, Douglas C Hodgins, Albert Z Kapikian, Yasutaka Hoshino.   

Abstract

Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus enterotoxin nonstructural protein (NSP)-4, independent neutralization antigens viral protein (VP)-4 and VP7, and group A rotavirus common antigen VP6 were analyzed by an immunocytochemistry assay in infants who received 1 of several live oral rotavirus vaccines. Significant serum immunoglobulin (Ig) A and IgG antibody responses to homotypic and/or heterotypic NSP4s of genotype [A], [B], or [C] were detected after vaccination. The magnitude of antibody responses to homotypic and heterotypic NSP4s was not significantly different, irrespective of the NSP4 genotype of the administered vaccine strain. In addition, there were no significant differences between IgA antibody responses to homotypic and heterotypic VP7s. In contrast, IgA antibody responses to VP4 were predominantly homotypic. IgA antibody responses to VP7 were lower in magnitude than those to VP4 but were comparable to those to NSP4. Antibody titers to homotypic and/or heterotypic NSP4s were positively correlated with those to VP6 before and after vaccination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15122520     DOI: 10.1086/383416

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Genetic variability among serotype G4 Italian human rotaviruses.

Authors:  S Arista; G M Giammanco; S De Grazia; C Colomba; V Martella
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs.

Authors:  Sonia Cheetham; Menira Souza; Tea Meulia; Sheila Grimes; Myung Guk Han; Linda J Saif
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

3.  Evaluation of serum antibody responses against the rotavirus nonstructural protein NSP4 in children after rhesus rotavirus tetravalent vaccination or natural infection.

Authors:  Esmeralda Vizzi; Eva Calviño; Rosabel González; Irene Pérez-Schael; Max Ciarlet; Gagandeep Kang; Mary K Estes; Ferdinando Liprandi; Juan E Ludert
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  The rotavirus enterotoxin NSP4 directly interacts with the caveolar structural protein caveolin-1.

Authors:  Rebecca D Parr; Stephen M Storey; Deanne M Mitchell; Avery L McIntosh; Minglong Zhou; Kiran D Mir; Judith M Ball
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

5.  Resistance to rotavirus infection in adult volunteers challenged with a virulent G1P1A[8] virus correlated with serum immunoglobulin G antibodies to homotypic viral proteins 7 and 4.

Authors:  Lijuan Yuan; Shinjiro Honma; Inyoung Kim; Albert Z Kapikian; Yasutaka Hoshino
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

6.  A longitudinal cohort study in calves evaluated for rotavirus infections from 1 to 12 months of age by sequential serological assays.

Authors:  Dianjun Cao; Blessing Igboeli; Lijuan Yuan; Albert Z Kapikian; Jess L Ayers; Francis R Abinanti; Yasutaka Hoshino
Journal:  Arch Virol       Date:  2009-04-03       Impact factor: 2.574

7.  Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain).

Authors:  M Souza; S M Cheetham; M S P Azevedo; V Costantini; L J Saif
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

8.  Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus.

Authors:  M Souza; M S P Azevedo; K Jung; S Cheetham; L J Saif
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

9.  A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.

Authors:  Menira Souza; Veronica Costantini; Marli S P Azevedo; Linda J Saif
Journal:  Vaccine       Date:  2007-10-05       Impact factor: 3.641

Review 10.  Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.

Authors:  Juana Angel; A Duncan Steele; Manuel A Franco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.